3SBio to go private in $340 mln deal
Feb 8 (Reuters) - Chinese biotechnology firm 3SBio Inc said it agreed to be bought by Decade Sunshine Ltd for about $340 million.
The offer of $15.40 per American Depositary Shares (ADS) is at a premium of about 12 percent to the ADS's Thursday close of $13.79.
3SBio Chief Executive Jing Lou had offered to take the company private for up to $15 per ADS, or about $331 million, last September.
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.